drugset
Drugs / VB-C01 cellularised patch
last change Sep 2025 re-read 3 minutes ago

VB-C01 cellularised patch

Cell therapy

Developed for
heart failure · myocardial infarction
Investigated by
Clinica Universidad de Navarra, Universidad de Navarra · Hospital General Universitario Gregorio Marañon · KCRI Sp. z o.o. · Medical University of Silesia · Viscofan

Trials 1

today NCT06956807 · Ph 1
20262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06956807 Sep 2025 → Dec 2026 expected heart failure, myocardial infarction Viscofan Not yet recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as VB-C01 cellularised patch ClinicalTrials.gov intervention name — accepted as the source's own label NCT06956807 ↗
Modality Cell therapy “a membrane seeded with allogeneic adipose tissue derived stem cells” NCT06956807 ↗
Route Other “surgical epicardial implantation” NCT06956807 ↗